Seroprevalence of hepatitis B, hepatitis C, and human immunodeficiency virus infections in children with cancer at diagnosis and following therapy in Turkey

Medical and Pediatric Oncology

Volumn 34, Issue 2, 2000, Pages 102-105

  Kebudi, Rejin ^a   Ayan, Inci ^a   Yílmaz, Gülden ^b   Akící, Ferhan ^a   Görgün, Ömer ^a   Badur, Selim ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cancer; HBV; HCV; HIV; Pediatric oncology; Transfusions

Indexed keywords

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE; SOLID TUMOR; TURKEY (REPUBLIC); VIRUS DETECTION;

EID: 0033980983     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-911x(200002)34:2<102::aid-mpo5>3.0.co;2-%23     Document Type: Article

References (16)

1. Kebudi R, Agaoglu L, Badur S. The seroprevalance of HIV-1 and HBV infections in multitransfused pediatric hematology-oncology patients in Istanbul. Pediatr Hematol Oncol 1992;9:389-391.
2. Hoofnagle JH, Dusheiko GM, Schafer DF, et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982;96:447-449.
3. Myers B, Irving W, Hollingsworth R, et al. Hepatitis C in multitransfused children with hematological malignancy. Br J Haematol 1995;91:480-482.
4. Neilson JR, Harrison P, Skidmore SJ, et al. Chronic hepatitis C in long term survivors of haematological malignancy treated in a single centre. J Clin Pathol 1996;49:230-232.
5. Fisher M. Transfusion associated acquired immunodeficiency syndrome - what's the risk? Pediatrics 1987;79:156-160.
6. Akyol H, Sarialioglu F, Büyükpamukçu M, et al. Hepatitis B virus infections in pediatric patients receiving anti-cancer chemotherapy. Turk J Cancer 1990;20:104-108.
7. Çetingül N, Kavakli K, Vergin C, et al. Hepatitis-B, hepatitis-C, CMV and HIV markers in pediatric malignancies. Turk J Cancer 1994;24:175-180.
8. Berberoglu S. The seroprevalance of hepatitis B, hepatitis C and human immundeficiency virus infections in pediatric oncology patients in Turkey. Postgrad Med J 1996;72:609-611.
9. Badur S. Viral hepatitis in Turkey. Status report of the Turkish Society for Prevention of Viral Hepatitis (in Turkish). In: Kiliçturgay K, editor. Viral hepatitis 94. Istanbul: Nobel Tip Publisher; 1994. p 15-38.
10. Yelken RH. Solid phase enzyme immunoassays for the detection of microbial antigens in body fluids. In: Lenette EH, Balows A, Hausler WJ, Shadomy HJ, editors. Manual of clinical microbiology, 4th ed. Washington, DC: American Society for Microbiology; 1985. p 949-957.
11. Ariogul S, Akalin E, Kanra T. HBsAg among Turkish blood donors. Infection 1987;15:456.
12. Berberoglu S, Büyükpamukçu M, Sarialioglu F, et al. Hepatitis B vaccination in children with cancer. Pediatr Hematol Oncol 1995; 12:171-178.
13. Entacher U, Jürgenssen O, Simbruner G, et al. Hepatitis B vaccination and immune response in children with malignant disease. Eur J Pediatr 1985;144:160-163.
14. Hoofnagle JH; Seeff LB, Bales ZB. et al. Passive-active immunity from hepatitis B immunoglobulin. Ann Intern Med 1979;91:813-818.
15. Boguslawska Jaworska J, Gorczynska E, Seyried H, et al. Passive and active antihepatitis B immunization of children with hematological malignancies. Hematol Blood Transfus 1987;30:530-534.
16. American Academy of Pediatrics. Hepatitis C. In: Peter G, editor. 1997 Red book. Report of the Committee on Infectious Diseases, 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997. p 260-264.